IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
560.73
+9.91 (1.80%)
At close: Jun 3, 2026, 4:00 PM EDT
568.72
+7.99 (1.42%)
After-hours: Jun 3, 2026, 7:59 PM EDT
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$404,190
Profits / Employee
$99,567
Market Cap
44.23B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,000 | 0 | - |
| Dec 31, 2024 | 11,000 | 0 | - |
| Dec 31, 2023 | 11,000 | 220 | 2.04% |
| Dec 31, 2022 | 10,780 | 430 | 4.15% |
| Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
| Dec 31, 2020 | 9,300 | 100 | 1.09% |
| Dec 31, 2019 | 9,200 | 823 | 9.82% |
| Dec 31, 2018 | 8,377 | 777 | 10.22% |
| Dec 31, 2017 | 7,600 | 235 | 3.19% |
| Dec 31, 2016 | 7,365 | 565 | 8.31% |
| Dec 31, 2015 | 6,800 | 400 | 6.25% |
| Dec 31, 2014 | 6,400 | 700 | 12.28% |
| Dec 31, 2013 | 5,700 | 300 | 5.56% |
| Dec 31, 2012 | 5,400 | 300 | 5.88% |
| Dec 31, 2011 | 5,100 | 300 | 6.25% |
| Dec 31, 2010 | 4,800 | 0 | - |
| Dec 31, 2009 | 4,800 | 100 | 2.13% |
| Dec 31, 2008 | 4,700 | 0 | - |
| Dec 31, 2007 | 4,700 | 800 | 20.51% |
| Dec 31, 2006 | 3,900 | 600 | 18.18% |
| Dec 31, 2005 | 3,300 | 305 | 10.18% |
| Dec 31, 2004 | 2,995 | 522 | 21.11% |
| Dec 31, 2003 | 2,473 | 292 | 13.39% |
| Dec 31, 2002 | 2,181 | 11 | 0.51% |
| Dec 31, 2001 | 2,170 | -80 | -3.56% |
| Dec 31, 2000 | 2,250 | 200 | 9.76% |
| Dec 31, 1999 | 2,050 | -50 | -2.38% |
| Dec 31, 1998 | 2,100 | 0 | - |
| Dec 31, 1997 | 2,100 | 585 | 38.61% |
| Dec 31, 1996 | 1,515 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Danaher | 60,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| Illumina | 10,080 |
| Waters | 7,900 |
IDXX News
- 7 days ago - IDEXX Laboratories Transcript: Stifel Jaws & Paws Conference 2026 - Transcripts
- 8 days ago - Idexx Laboratories expands Fecal Dx platform for taeniid tapeworm detection - TheFly
- 8 days ago - IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection - Business Wire
- 15 days ago - Idexx Laboratories announces SDMA to be built into Catalyst CLIPs - TheFly
- 15 days ago - IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles - Business Wire
- 20 days ago - IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day - Business Wire
- 22 days ago - IDEXX Laboratories Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Idexx Laboratories price target lowered to $660 from $790 at BofA - TheFly